GKGlaucia Denise Kommers

Glaucia Denise Kommers

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Glaucia Denise Kommers has a total of 279 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hepatic lipogranulomas in canine visceral leishmaniasis: Morphological and immunohistochemical characterization using IBA-1 and MAC387

    by Indianara de Vargas, Valentina B. Marcus, Eduarda M.T. Santi, Thainã P. Vargas, Flavia A. Sangoi, Diego F. Sturza, Rafael A. Fighera, Glaucia D. Kommers, Mariana M. Flores

  • Open Access

    Disseminated cutaneous mast cell tumor in a South American coati (Nasua nasua)

    by Renata Dalcol Mazaro, Gabriela Hartmann, Diego Cardoso, Tereza Cristina Da Silva, Bruno Cogliati, Glaucia Denise Kommers, Rafael Almeida Fighera

    Cutaneous mast cell tumors have been described in all species of domestic mammals. However, information about these tumors in free-ranging and captive wild mammals is limited, with no reports in procyonids. This report aims to describe a case of disseminated cutaneous mast cell tumor in a captive South American coati ( Nasua nasua ). The animal was submitted to euthanasia and necropsy. On external examination, multiple papules, nodules, and plaques were distributed over the body surface. On cut section, they were soft and white. Histologically, they were composed of dense sheets of neoplastic cells interspersed with a delicate collagenous stroma. Cells were round and had a finely granular cytoplasm. Mast cell tumors were diagnosed based on histological features, positive staining with toluidine blue, and immunohistochemical labelling for the KIT protein. To the best of our knowledge, this is the first report of disseminated cutaneous mast cell tumor in this animal species.

  • Open Access

    Search for Equus caballus papillomavirus type 2 in tissues of asymptomatic horses in southern brazil

    by Eduarda Maria Trentin Santi, Joana Braga Pecego, Maria Fernanda Abel Schirmer, Thainã Piccolo Vargas, Valentina Berté Marcus, Indianara de Vargas, Glaucia Denise Kommers, Mariana Cocco, Nathalia de Freitas Michelon, Eduardo Furtado Flores, et al.

    Equus caballus papillomavirus type 2 (EcPV-2) has been recently associated with the development of genital squamous cell carcinomas in horses. Nevertheless, its circulation among healthy, asymptomatic horses remains poorly understood. This study aimed to investigate the presence of EcPV-2 DNA in asymptomatic horses submitted to necropsy in southern Brazil. A total of 54 horses without clinical or histological evidence of genital lesions were investigated: 40 necropsied animals and penile mucosa specimens collected from 14 horses at a local abattoir. Tissue samples were subjected to histological analysis and polymerase chain reaction targeting a 306 bp fragment of the EcPV-2 L1 gene. EcPV-2 DNA was detected in one animal (1.85%). The sample was obtained from a necropsied male horse that died due to acute intestinal disease. Sequencing of the amplicon obtained in the PCR confirmed the identity of the viral fragment, and phylogenetic analysis clustered the sequence with known EcPV-2 isolates. No histological lesions were observed in any of the tissues examined from the animal containing amplifiable EcPV-2 DNA. This is the first report of EcPV-2 DNA detection in the genital mucosa of an asymptomatic horse in Brazil, supporting the possibility of subclinical infection. These findings provide initial evidence that EcPV-2 may occur in clinically normal horses in Brazil and highlight the need for further studies to determine the prevalence of subclinical infection and the potential role of asymptomatic carriers in viral transmission.

  • Postmortem Detection of Blood Vascular Tumour‐Cell Emboli in 31 Dogs: Macroscopic and Histological Findings

    by Helenize Molozzi, Vanessa Cirinéa Tapia Barraza, Valentina Berté Marcus, Isabela de Aro Jorge Tavares, Maria Vitória Girol Sanches, Beatriz Regina Britz Zimmer, Bruna Karine Britz Zimmer, Flavia Alassia Sangoi, Rafael Almeida Fighera, Glaucia Denise Kommers, et al.

    Despite the high prevalence of neoplastic diseases in dogs, tumour‐cell embolism is poorly documented. This study aimed to characterise the presence and pathological features of distant blood vascular tumour‐cell emboli (TCE) in dogs submitted for necropsy. TCE were histologically confirmed in 31/528 dogs (5.9%) that died or were euthanized due to neoplastic disease, most frequently mammary carcinomas (17/31, 54.8%). In 15/31 dogs (48.4%), TCE were associated with secondary macroscopic lesions, such as haemorrhage, whereas in 16/31 dogs (51.6%), there was no clear association with additional pathological changes. TCE were most commonly observed in the lungs (25/31), kidneys (9/31), adrenals (5/31), brain (5/31), and myocardium (5/31). Macroscopic pulmonary changes included petechiae or suffusions (8/31), and TCE‐associated haemorrhages were also observed in the myocardium (4/31), kidneys (2/31), adrenals (2/31), brain (2/31), and gastrointestinal serosae (2/31). Histological lesions associated with TCE included haemorrhage (18/31), thrombosis (11/31), oedema (8/31), infarcts (7/31), and intimal proliferation and perivascular fibrosis (4/31). Taken together, these findings suggest that blood vascular TCE may be more prevalent in dogs than currently recognised and reinforce the importance of careful pathological evaluation for their detection. The clinical, macroscopic, and microscopic features described herein provide a practical framework for recognising TCE in veterinary pathology and underscore the need for further studies addressing their pathogenesis, clinical significance, and impact on disease progression in dogs.

  • Open Access

    Traumatic Marjolin’s ulcer in sheep: Squamous cell carcinoma arising from chronic dorsal fence-wire injuries

    by Telma Sousa Lima, Francisco das Chagas Sarmento Júnior, Francisca Maria Sousa Barbosa, Elizandra Teixeira Melo, Silvio Miguel Castillo, Harlan Hallamys Lima Nascimento, Glaucia D. Kommers, Ricardo Barbosa Lucena


  • Open Access

    Hepatocyte syncytial formation in feline leukemia virus infected young cats

    by Douglas Miotto Lorenzetti, Eduarda Maria Trentin Santi, Daniele Gomes Rodrigues, Luisa Paim Do Amorim, Bruna Karine Britz Zimmer, Bruno Cogliati, Rafael Almeida Fighera, Glaucia Denise Kommers, Mariana Martins Flores

    Giant cell hepatitis (GCH) is an uncommon hepatic lesion in mammals, and rarely reported in domestic cats. This study described the anatomopathological features and immunoexpression of HepPar-1 and feline leukemia virus glycoprotein 70 (FeLV gp70) in three FeLV-positive domestic cats with hepatocyte syncytial formation resembled GCH. The cats did not present any clinical sign of hepatic failure; however, one of the patients exhibited elevated alanine aminotransferase activity. Grossly, the livers were moderately enlarged, slightly pale, and exhibited mild lobular pattern accentuation. Histologically, lesions included hepatocyte dissociation, hepatocellular necrosis, multinucleated and/or enlarged hepatocytes displaying karyomegaly. Normal and altered hepatocytes showed immunolabeling for HepPar-1 and FeLV gp70. The findings reinforce the need to consider GCH as a differential diagnosis in cats with unexplained elevations in liver enzymes, particularly when infected with FeLV.

  • Open Access

    Toxoplasma gondii, Neospora caninum, and Sarcocystis spp. in brain samples of dogs with and without neurological signs in Southern Brazil (2008-2023)

    by Ananda Segabinazzi Ries, Isac Junior Roman, Ana Paula Gnocatto Mortari, Eduarda Trentin Santi, Mariana Martins Flores, Glaucia Denise Kommers, Rafael Almeida Fighera, Juliana Felipetto Cargnelutti, Luis Antonio Sangioni, Fernanda Silveira Flôres Vogel

    Encephalitis can be associated with protozoa of the phylum Apicomplexa. Sarcocystis spp., Toxoplasma gondii, and Neospora caninum share morphological similarities that complicate differentiation in histopathology, leading to inaccurate diagnoses without complementary techniques. Clinical manifestations often associate with host immunosuppression secondary to other diseases. This study examined brain samples from dogs undergoing necropsy in Rio Grande do Sul, Brazil, from 2008 to 2023, using two groups: dogs with neurological signs caused by protozoa (G1) and dogs without neurological signs (G2). G1 aimed to verify if protozoa identified histopathologically matched molecular techniques. G2 observed the frequency of protozoa detection using PCR in dogs without neurological signs. A total of 230 samples were analyzed: 11 paraffin-embedded in G1 and 219 frozen in G2. DNA extraction used commercial kits, and all samples underwent PCR for the 18S rRNA gene. G1 samples also underwent Restriction Fragment Length Polymorphism (RFLP) analysis. Protozoal DNA was detected in six samples (6/11) from G1 with varying molecular identifications. In G2, 82 samples (82/219; 37.45%) were PCR-positive. These findings highlight the importance of molecular techniques for accurate etiological confirmation and diagnosis, extending epidemiological knowledge and emphasizing Toxoplasma gondii, Neospora. caninum, and Sarcocystis spp. as differential diagnoses for central nervous system diseases in dogs.


  • Open Access

    Histiocytic sarcoma in dogs: epidemiology, anatomopathology, and immunohistochemistry

    by Flávia S. Da Luz, Renata D. Mazaro, Gabriela Hartmann, Tereza Cristina Da Silva, Bruno Cogliati, Lilian R. Marques de Sá, Glaucia D. Kommers, Alexandre A. Tonin, Rafael A. Fighera

    Histiocytic sarcomas have been described in veterinary medicine since 1980, but studies on the subject are still scarce. Based on this, the objective of this article is to describe the epidemiological, anatomopathological and immunohistochemical aspects of histiocytic sarcoma in dogs submitted to necropsy in a diagnostic service covering the midwestern region of Rio Grande do Sul State, Brazil. From 2007 to 2021, 4,310 dogs were necropsied, of which 598 died or were euthanized due to some type of cancer. At least 18 cases of histiocytic sarcoma were diagnosed, i.e., 3% of cancer deaths and 0.4% of total deaths. The criterion used to establish the definitive diagnosis and inclusion in the study was an interaction between characteristic histopathology and positive immunostaining for CD204. Almost all (17/18, 94.4%) of these patients were of a defined breed and were large, with the vast majority (14/18, 77.8%) being Rottweiler. There was a predominance of disseminated histiocytic sarcoma (15/18, 83.3%) affecting several organs, while 10 (66.7%) affecting the lungs, liver, spleen and lymph nodes were affected concomitantly. Of the few cases (3/18, 16.7%) diagnosed as localized histiocytic sarcoma, where lungs were affected. Five different presentation patterns were observed macroscopically, not mutually exclusive: multinodular, massive, diffuse, peribronchiolar, and placoid. The most affected organs were the lungs (17/18, 94.4%), lymph nodes (15/18, 83.3%), liver (13/18, 72.2%), spleen (12/18, 66.7%), kidneys (6/15, 60%) and heart (6/15, 40%). Other less affected organs included adrenals (4/15, 26.7%), skeletal muscle (diaphragm) (4/15, 26.7%), bones (2/15, 13.3%), pancreas (2/15, 13.3%), pericardial sac (2/15, 13.3%), joint (1/15, 6.7%), omentum (1/15, 6.7%) and parietal pleura (1/15, 6.7%). Histologically, histiocytic sarcoma was characterized by a non-delimited, mantle-shaped proliferation with a scant stroma of round cells, many markedly anaplastic, often giving the tumor a rather pleomorphic appearance. A hallmark was the occurrence of a variable, but often high, number of mono, bi and multinucleated giant cells (30-100 µm in diameter), which always had large nuclei (karyomegaly) formed by loose chromatin and with nucleoli almost always multiple and conspicuous. Although there are peculiarities in the neoplastic involvement in each affected organ, in general, this proliferation tends to obscure the affected parenchyma and often invades and obliterates lymphatic and blood vessels. About 90% of neoplastic cells, including the most anaplastic and many of the multinucleated ones, immunostained strongly for CD204 and MHC-II but not for CD11d, confirming that they were histiocytes, other than splenic/bone marrow macrophages. It is hoped that this information will contribute to a better characterization of histiocytic sarcoma in the canine species and may help veterinary pathologists in their diagnostic routines.


  • Open Access

    Primary ovarian leiomyosarcoma in a dog - case report

    by F.S. Flores, C.C. Rosa, A.V. Hörbe, C.K.N. Calva, G.R. Cassanego, G.D. Kommers, L.F.D. Corrêa

    Leiomyosarcoma is the most common malignant mesenchymal tumor found in the retroperitoneal and intra-abdominal regions, while its ovarian location is considered rare in bitches and is scarce in the literature due to its underdiagnosis. A 12-year female dog of no defined breed was seen presenting with an increase in volume in the right flank region and tenderness on palpation caudal to the last right rib. Considering the suspicion of an abdominal neoplasm, the patient underwent ultrasound, which detected the presence of a heterogeneous mass in the right ovary. For diagnostic purposes, an exploratory celiotomy was performed, in which the 18x15x8cm mass was excised and sent for histopathological analysis. Multiple cysts were detected in the left ovary and pyometra in both uterine horns. Histopathological examination showed non-encapsulated neoplastic proliferation, composed of mesenchymal cells, neoplastic cells with indistinct cytoplasmic boundaries, eosinophilic fibrillar cytoplasm, oval or fusiform nuclei, finely granular chromatin and a single conspicuous nucleolus, making the diagnosis highly compatible with leiomyosarcoma in the right ovary. To confirm the histogenesis, the IHC technique was used. As a result, complementary tests become essential tools for better diagnosis and correct therapy in these disorders, as they present specific clinical signs.